Murthy KS. Increased PDE5 activity and decreased Rho kinase and PKC activities in colonic muscle from caveolin-1 Ϫ/Ϫ mice impair the peristaltic reflex and propulsion. Am J Physiol Gastrointest Liver Physiol 305: G964 -G974, 2013. First published October 24, 2013 doi:10.1152/ajpgi.00165.2013.-Caveolae are specialized regions of the plasma membrane that concentrate receptors and associated signaling molecules critical in regulation of cellular response to transmitters and hormones. We have determined the effects of caveolin-1 (Cav-1) deletion, caveolin-1 siRNA, and caveolar disruption in mice on the signaling pathways that mediate contraction and relaxation in colonic smooth muscle and on the components of the peristaltic reflex in isolated tissue and propulsion in intact colonic segments. In Cav-1 Ϫ/Ϫ mice, both relaxation and contraction were decreased in smooth muscle cells and muscle strips, as well as during both phases of the peristaltic reflex and colonic propulsion. The decrease in relaxation in response to the nitric oxide (NO) donor was accompanied by a decrease in cGMP levels and an increase in phosphodiesterase 5 (PDE5) activity. Relaxation by a PDE5-resistant cGMP analog was not affected in smooth muscle of Cav-1 Ϫ/Ϫ mice, suggesting that inhibition of relaxation was due to augmentation of PDE5 activity. Similar effects on relaxation, PDE5 and cGMP were obtained in muscle cells upon disruption of caveolae by methyl-␤-cyclodextrin or suppression of Cav-1. Sustained contraction mediated via inhibition of myosin light chain phosphatase (MLCP) activity is regulated by Rho kinase and PKC via phosphorylation of two endogenous inhibitors of MLCP: myosin phosphatasetargeting subunit (MYPT1) and 17-kDa PKC-potentiated protein phosphatase 1 inhibitor protein (CPI-17), respectively. The activity of both enzymes and phosphorylation of MYPT1 and CPI-17 were decreased in smooth muscle from Cav-1 Ϫ/Ϫ mice. We conclude that the integrity of caveolae is essential for contractile and relaxant activity in colonic smooth muscle and the maintenance of neuromuscular function at organ level.
role in regulating the response to agonists at the cellular level; however, the translation of these cellular effects of caveolin to the organ level is less well understood although many roles have been postulated (1, 25, 43-45, 50, 58) .
In the gut, caveoli are present on many cell types, including smooth muscle cells, interstitial cells of Cajal (ICC), and endothelial cells (14, 15, 26, 42) . Previous studies have indicated that caveoli and, in particular, Cav-1 play a key role in cholinergic, tachykininergic, and nitrigeric responses of ICC and smooth muscle (3, 6, 14, 15, 26, 48, 49) . Acetylcholine (ACh) and substance P (SP) represent the main contractile transmitters of the gut and mediate the ascending contraction component of the peristaltic reflex, whereas nitric oxide (NO) and vasoactive intestinal peptide represent the main relaxant transmitters of the gut and mediate the descending relaxation component of the peristaltic reflex (19) . The coordinated contraction of circular muscle orad to a chemical or mechanical stimulus and relaxation caudad to a stimulus leads to propulsion. Interference with either ascending contraction or descending relaxation strongly impairs propulsion (17) .
Studies in Cav-1 Ϫ/Ϫ mice have shown that, in the small intestine, there is loss of caveoli formation, which is accompanied by loss of NO synthase in smooth muscle and ICC but not neurons (13, 16) . Relaxation in these mice induced by the NO donor sodium nitroprusside (SNP) was reduced, but there is no reduction in relaxation induced by 8-bromo-cGMP, suggesting that, in Cav-1 Ϫ/Ϫ mice, the reduction in relaxation was not due to loss of response to cGMP. Given the key role of NO in the descending phase of the peristaltic reflex (19) , we hypothesized that this phase of the reflex would be reduced in Cav-1 Ϫ/Ϫ mice and that the net result would be a decrease in colonic propulsion.
Caveoli are also intimately involved in contraction of gut smooth muscle. Contractile agonists such as ACh induce initial contraction via activation of G q /phospholipase C-␤1, resulting in 1,4,5-inositol triphosphate-dependent Ca 2ϩ release, myosin light chain (MLC) kinase-mediated MLC 20 phosphorylation, sustained contraction via activation of G q/13 /RhoA, Rho kinase-dependent phosphorylation of myosin phosphatase-targeting subunit 1 (MYPT1), and PKC-dependent phosphorylation of 17-kDa PKC-potentiated protein phosphatase 1 inhibitor protein (CPI-17), resulting in MLC phosphatase inhibition and MLC 20 phosphorylation (8, 28, 34, 40) . The initial phase of contraction is rapid, whereas the sustained contraction pathways are established within 30 s and sustained up to 20 min (34) . The ascending contraction component of the peristaltic reflex lasts as long as the stimulus is present and thus likely involves both mechanistic contraction pathways (19) . Interference with any component of this contractile signaling pathway in Cav-1 Ϫ/Ϫ mice would interfere with the cholinergic component of ascending contraction and also decrease colonic propulsion.
In the present study, we have used a multitiered approach to determine the effects of interference with caveolae formation on contraction and relaxation during the peristaltic reflex. Furthermore, we have extended this to the descending relaxation and ascending contraction components of the peristaltic reflex and colonic propulsion of fecal pellets. The results showed that, in Cav-1 Ϫ/Ϫ mice, the descending relaxation and ascending contraction components of the peristaltic reflex were both depressed compared with wild-type mice, resulting in reduced velocity of pellet propulsion. Studies in muscle cells isolated from the colon of the Cav-1 Ϫ/Ϫ mice and from wild-type cells treated with methyl-␤-cyclodextrin (M␤-CD) or siRNA for Cav-1 revealed the cellular mechanisms responsible for the reduced peristalsis and propulsion. The reduction in descending relaxation could be due to removal of inhibition of phosphodiesterase 5 (PDE5) normally exerted by the binding of Cav-1 to PDE5 (18) , thus leading to enhanced degradation of cGMP and reduced relaxation in response to NO. The reduction in ascending contraction could be due to reduced PKC and Rho kinase activity and resultant CPI-17 and MYPT1 phosphorylation in response to ACh (3). The loss of key excitatory and relaxant pathways results in impaired pellet propulsion.
MATERIALS AND METHODS

Animals.
Wild-type (WT) and caveolin-1 knockout (Cav-1 Ϫ/Ϫ ) mice were bred on a C57BL/6 background and were purchased from Jackson Laboratories (Bar Harbor, ME). Animals were housed on a 12-h:12-h dark/light cycle and allowed food and water ad libitum. The mice were killed by CO 2 asphyxiation followed by thoracotomy. The colon was quickly removed into iced Krebs buffer bubbled with 95% O 2-5% CO2 at 32°C before preparation of muscle strips, isolated cells, or whole segment peristaltic preparations. All procedures were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University.
Preparation of muscle strips. Muscle cells were isolated from the circular muscle layer of the colon as described previously (29 -34) . Sections of colon were threaded over a glass rod and stroked along the mesenteric attachment to separate longitudinal muscle with the adherent myenteric plexus. The mucosa was dissected away from the circular muscle and discarded. The remaining circular muscle sheet was cut into small strips. Three-to four-millimeter-wide muscle strips were cut from these sheets of muscle. Muscle strips were used for preparation of isolated muscle cells and for measurement of isometric relaxation, generation of cGMP, and activity of PDE5.
Measurement of isometric relaxation in muscle strips. Muscle strips were mounted in organ baths containing Krebs buffer maintained at 37°C and bubbled with 95% O 2-5% CO2 at a resting load of 1 g and allowed to equilibrate for 1 h. Isometric responses were measured with Grass FT03 force displacement transducers attached to muscle strips. Muscle strips were precontracted with 1 M carbachol (CCh) to raise tone, and SNP (1 pM-10 M) was added in a cumulative manner to induce relaxation, which was calculated as decrease from maximal CCh-induced tone.
Preparation of isolated muscle cells. Smooth muscle cells were isolated from muscle strips by sequential enzymatic digestion, filtration, and centrifugation as described previously (34) . Suspensions of cells were used to measure relaxation and contraction, generation of cGMP, CPI-17 and MYPT1 phosphorylation, and PDE5, PKC, and Rho kinase activity. In some cases, isolated muscle cells were placed into culture and used in first passage as described previously (53) , and in other cases isolated cells were treated with M␤-CD (5 mM), which has been shown to disrupt caveolae formation in numerous cell types (38) .
Measurement of contraction and relaxation in isolated muscle cells. Contraction and relaxation of isolated muscle cells were measured as described in detail previously (28, 34) . Briefly, suspensions of single muscle cells were incubated with buffer alone (control), ACh (1 M), KCl (20 mM), KCl plus SNP, KCl plus 8-pCPT-cGMP, or KCl plus S-nitrosoglutathione (GSNO) (10 M). After 30 s, the reaction was stopped with 0.1% acrolein, and the lengths of 50 cells were measured by scanning micrometry. Experiments were blinded to avoid viewer bias. The mean length was calculated, and contraction was measured as decrease in cell length in micrometers from that obtained in cells incubated in buffer alone (28, 34) . Relaxation in response to SNP, 8-pCPT-cGMP, or GSNO was calculated as a decrease in KCl-induced contraction. For measurement of sustained contraction, the same procedure was used except that ACh (1 M) or KCl (20 mM) was added for 10 min, and then the reaction was stopped with acrolein and the length of 50 cells measured by scanning micrometry.
Transfection of caveolin-1 siRNA. For transfection of siRNA, the cells were washed and cultured in DMEM medium containing 10% fetal bovine serum and antibiotics until they attained confluence and used after first passage in various experiments. The RNAi-Ready pSIREN-DNR-DsRed-Express Vector (BD Biosciences, Clontech) encoding caveolin-1 small-interfering RNA (Qiagen) was inserted between BamH1 and EcoR1 restriction sites and transfected into cultured smooth muscle cells with Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's recommendation (37) . To check the specificity of the siRNA, empty vector without the siRNA sequence was used as control. Successful knockdown of caveolin-1 protein was verified by Western blot.
Measurement of cGMP. Generation of cGMP was measured in isolated muscle cells and in muscle strips as described previously by radioimmunoassay using [
125 I]cGMP (27) . Smooth muscle cells were aliquoted (0.5 ml) and treated with SNP (1 M) or GSNO (10 M), and the reaction was terminated with 6% trichloroacetic acid (vol/vol). The mixture was centrifuged, and the supernatant was extracted three times with diethyl ether and lyophilized. Muscle strips were incubated with SNP (1 pM to 10 M) for 30 s and the reaction stopped by homogenization in lysis buffer. The homogenate was treated as described for muscle cells. The samples were reconstituted in 500 l of 50 mM sodium acetate (pH 6.2) and acetylated with triethylamine/ acetic anhydride (2:1 vol/vol) for 30 min. Cyclic GMP was measured in triplicates using 100-l aliquots, and the results were analyzed from standard curves using PRISM (GraphPad) program.
Measurement of PDE5 activity. PDE5 activity was measured by the method of Wyatt et al. (57) as described previously (27) . Muscle strips or muscle cells were incubated with SNP or GSNO, the tissue homogenized, and PDE5 isolated by immunoprecipitation. PDE5 immunoprecipitates were washed in a medium containing 50 mM Tris (pH 7.5), 200 mM NaCl, 5 mM EDTA and then incubated for 15 min at 30°C in a reaction mixture containing 100 mM 2-[N-morpholino] ethanesulphonic acid (pH 7.5), 10 mM EDTA, 0.1 M Mg acetate, 0.9 mg/ml bovine serum albumin, 20 M cGMP, and [
3 H]cGMP. The samples were boiled for 3 min, chilled for 3 min, and then incubated at 30°C for 10 min in 20 mM Tris (pH 7.5) medium containing 10 l of Crotalus atrox snake venom (10 g/l). The samples were added to DEAE-Sephacel A-25 columns, and the radioactivity in the effluent was counted. The results are expressed as counts per minute per milligram of protein (cpm/mg protein).
Measurement of Rho kinase activity in isolated muscle cells. Rho kinase activity was measured by immunokinase assay as previously described (33) . Following treatment with ACh (1 M) or KCl (20 mM), muscle cells were permeabilized, and Rho kinase was immu-noprecipitated with specific antibody (sc-1852, Santa Cruz Biotechnology). The immunokinase assay was initiated by the addition of 10 Ci of [␥-
32 P]ATP (3,000 Ci/mmol) and 20 M ATP for 10 min at 37°C along with 1 g of myelin basic protein as substrate and absorbed on to phosphocellulose discs followed by repeated washings with 75 mM phosphoric acid to remove nonspecific radioactivity. The amount of 32 P incorporation on the discs was measured by liquid scintillation.
Measurement of PKC activity in isolated muscle cells. PKC activity was measured in the particulate fraction as described previously (31) . One milliliter of suspension of isolated cells (2 ϫ 10 6 cells/ml) was incubated with ACh (1 M) or KCl (20 mM) and the reaction terminated by rapid freezing. The suspension was thawed, homogenized in 20 mM Tris·HCl containing 250 mM sucrose, 1 mM EGTA, 10 mM mercaptoethanol, and 1 mM phenylmethylsulfonylfluoride (PMSF), pH 7.5 and centrifuged at 100,000 revolution/min at 4°C for 30 min. The supernatant was used as the cytosolic fraction. The pellet was resuspended in buffer containing 0.2% Triton X-100 and centrifuged at 100,000 revolution/min for 20 min, and the supernatant was used as the particulate fraction. PKC activity was measured by Ca 2ϩ /phospholipid-dependent incorporation of 32 P from [␥-32 P]ATP into histone as described before (31) and expressed as cpm/mg protein.
Measurement of phosphorylated CPI-17 and MYPT1 in isolated muscle cells. Phosphorylation of MYPT1 and CPI-17 was measured using phospho-specific antibodies as described previously (34) . One milliliter of cell suspension (2 ϫ 10 6 cell/ml) was treated with ACh (1 M) or KCl (20 mM) and solubilized on ice for 1 h in medium containing 20 mM Tris·HCl (pH 8.0), 1 mM DTT, 100 mM NaCl, 0.5% sodium dodecyl sulfate, 0.75% deoxycholate, 1 mM PMSF, 10 g/ml of leupeptin, and 100 g/ml of aprotinin. The proteins were resolved by SDS-PAGE and electrophoretically transferred on to nitrocellulose membranes. The membranes were incubated for 12 h with phospho-specific antibodies to MYPT1 (Thr 696 ) or CPI-17 (Thr 38 ) and then for 1 h with horseradish peroxidase-conjugated secondary antibody (1:2,000). The protein bands were identified by enhanced chemiluminescence reagent.
Association of PDE5 with caveolin-1. Antibody to caveolin-1 (sc-894, Santa Cruz Biotechnology) and PDE5 (2395, Cell Signaling) were used to determine the association of PDE5 with caveolin-1 by immunoprecipitation with caveolin-1 antibody followed by immunoblot with PDE5 antibody. Immunoprecipitates were separated by SDS-PAGE, transferred to PVDF membranes, and probed with antibody to PDE5. The proteins were visualized after incubation with secondary antibody.
Measurement of the ascending contraction and descending relaxation components of the peristaltic reflex. Whole segments of distal colon from wild-type and Cav-1 Ϫ/Ϫ mice (3-4 cm) were opened to form flat sheets, which were pinned mucosa side up in a threecompartment organ chamber as described previously (19) . Peristalsis was initiated by applying mucosal strokes (2-8 strokes) to the central section; descending relaxation was measured in the caudad compartment and ascending contraction in the orad compartment with forcedisplacement transducers attached to the circular muscle. Relaxation was calculated as decrease from spontaneous resting tone and contraction as the increase above spontaneous tone.
Measurement of pellet propulsion. Isolated segments of colon (5-6 cm) from wild-type and Cav-1 Ϫ/Ϫ mice were loosely pinned in an organ chamber as described previously (17) . After a 30-min equilibration, five artificial fecal pellets that mimic native pellets in size and shape were placed in the orad end separately, and the time to move through a set distance (3 cm) of the colon was measured. The velocity of propulsion of artificial fecal pellets was calculated as millimeters per second.
RESULTS
Relaxation in muscle strips. Addition of CCh (1 M) caused a rapid, tonic contraction, which maintained a plateau at 1.3 Ϯ 0.16 g tension above baseline. In muscle strips from the Cav-1 Ϫ/Ϫ mice, CCh-induced tonic contraction was decreased by 31 Ϯ 3% compared with wild-type mice and maintained at 0.87 Ϯ 0.06 g. Addition of the NO donor, SNP, to muscle strips derived from wild-type mice caused a concentration-dependent relaxation, which reached a maximal response (78 Ϯ 9% decrease in tone) at 10 M with an ED 50 of 12 Ϯ 3 nM (Fig. 1A) . In muscle strips from the Cav-1 Ϫ/Ϫ mice, the concentration-response curve for SNP-induced relaxation was shifted to the right, and a maximal response (47 Ϯ 7% decrease in tone) was obtained with 10 M with an ED 50 of 98 Ϯ 6 nM (Fig. 1A) . The maximal response, however, was significantly decreased in the Cav-1 Ϫ/Ϫ mice. Decrease in relaxation in Cav-1 Ϫ/Ϫ mice could be due to decrease in cGMP levels.
Cyclic GMP production in muscle strips. The effect of SNP on cGMP levels was measured in the absence of contractile agonists because our previous studies have shown that cGMP levels are cross regulated by contractile agonists via activation of PDE5 (29) . Addition of SNP to muscle strips derived from wild-type mice or Cav-1 Ϫ/Ϫ mice caused a concentrationdependent production of cGMP as measured by specific radioimmunoassay (Fig. 1B) . Basal levels of cGMP were not significantly different between wild-type (0.38 Ϯ 0.05 pmol/mg protein) and Cav-1 Ϫ/Ϫ mice (0.42 Ϯ 0.06 pmol/mg protein). In muscle strips from wild-type mice, SNP induced a maximal increase in cGMP of 3.1 Ϯ 0.25 pmol/mg protein at 10 M with an ED 50 of 7 Ϯ 3 nM (Fig. 1B) . In muscle strips from the Cav-1 Ϫ/Ϫ mice, the concentration-response curve for SNPinduced cGMP production was shifted to the right with a maximal increase of 1.98 Ϯ 0.2 pmol/mg protein at 10 M and an ED 50 of 182 Ϯ 25 nM (Fig. 1B) . The maximal response was significantly lower in the Cav-1 Ϫ/Ϫ mice. PDE5 activity in muscle strips. Cytosolic cGMP levels are regulated by their synthesis via soluble guanylyl cyclase (sGC) and degradation by PDE5 (6, 27) . The decrease in cGMP levels in Cav-1 Ϫ/Ϫ mice could be due to inhibition of sGC activity or stimulation of PDE5 activity. Earlier studies (18) had shown that PDE5 is associated with caveoli and Cav-1, leading us to hypothesize that PDE5 might be altered in the Cav-1 Ϫ/Ϫ mice and be involved in altered cGMP levels and relaxation. SNPinduced PDE5 activity was measured in the absence of the contractile agonist, CCh. Addition of SNP to muscle strips derived from wild-type mice or Cav-1 Ϫ/Ϫ mice caused a concentration-dependent activation of PDE5 (Fig. 1C) . Basal PDE5 activity was not significantly different between wildtype (524 Ϯ 69 cpm/mg protein) and Cav-1 Ϫ/Ϫ mice (631 Ϯ 79 cpm/mg protein). In muscle strips from wild-type mice, SNP induced a maximal increase in PDE5 activity (2,231 Ϯ 201 cpm/mg protein) at 10 M with an ED 50 of 86 Ϯ 7 nM (Fig. 1C) . Unlike SNP-induced relaxation and cGMP production, SNP-induced activation of PDE5 was enhanced in the Cav-1 Ϫ/Ϫ mice, consistent with the notion that binding of PDE5 to Cav-1 inhibits its activity. In muscle strips from the Cav-1 Ϫ/Ϫ mice, the concentration-response curve was shifted to the left and elevated compared with the curve obtained in muscle strips from wild-type mice (Fig. 1C) . The maximal stimulation of PDE5 activity (3,235 Ϯ 402 cpm/mg protein) was obtained at 10 M with an ED 50 of 9 Ϯ 1 nM. The maximal response was significantly higher in the Cav-1
Relaxation in isolated muscle cells. SNP-induced relaxation in muscle cells isolated from colonic segments of Cav-1 Ϫ/Ϫ mice was also inhibited compared with wild-type mice. Relaxation was measured as decrease in sustained contraction in response to KCl (20 mM (Fig. 2A) .
The notion that the decreased SNP-induced relaxation in Cav-1 Ϫ/Ϫ mice was due to increased PDE5 activity was examined using a PDE-resistant analog of cGMP, 8-pCPTcGMP. As illustrated in Fig. 2B, 8 -pCPT-cGMP induced relaxation in a concentration-dependent manner; maximal relaxation was similar in wild-type (62 Ϯ 3% relaxation; 13.2 Ϯ 2.1 m decrease in cell length in response to KCl) and Cav-1 Ϫ/Ϫ mice (59 Ϯ 4% relaxation; 14.1 Ϯ 2.6 m decrease in cell length in response to KCl). This is in contrast to the decreased SNP-induced relaxation in muscle cells isolated from Cav-1 Ϫ/Ϫ mice. These results suggest the possibility that PDE5 activity is negatively regulated by Cav-1.
Immunoblot analysis of Cav-1 immunoprecipitates showed association of PDE5 with caveolin-1 in the basal state, and the association was not affected by treatment of cells with GSNO (Fig. 3A) . The involvement of caveolae/caveolin-1 in the regulation of PDE5 activity, cGMP, and muscle relaxation was further examined in isolated muscle cells by depletion of cholesterol using M␤-CD and by suppression of caveolin-1 using caveolin-1-specific siRNA in cultured muscle cells. Depletion of cholesterol results in disruption of caveolae (2, 21, 38) . Pretreatment of cells with M␤-CD had no effect on basal PDE5 activity (511 Ϯ 68 cpm/mg protein) compared with control dimethyl sulfoxide-treated cells (439 Ϯ 46 cpm/mg protein). The NO donor GSNO (10 M)-induced PDE5 activity was significantly augmented (74 Ϯ 6% increase) by pretreatment of cells with M␤-CD (Fig. 3B) . In contrast, GSNO-induced cGMP formation was significantly attenuated (48 Ϯ 5% inhibition) by pretreatment of cells with M␤-CD (Fig. 3C) . Basal levels of cGMP were not significantly different between control cells (0.42 Ϯ 0.06 pmol/mg protein) and M␤-CD-treated cells (0.46 Ϯ 0.07 pmol/mg protein). Relaxation by GSNO, measured as inhibition of KCl-induced contraction, was also attenuated by pretreatment of cells with M␤-CD (Fig. 3D) . KCl-induced contraction, however, was similar in control cells (31. (Fig. 4A) . Transfection of Cav-1 siRNA had no effect on basal PDE5 activity (503 Ϯ 69 cpm/mg protein) compared with cells transfected with control siRNA (462 Ϯ 106 cpm/mg protein). GSNO-induced PDE5 activity, however, was significantly augmented by transfection of Cav-1 siRNA (60 Ϯ 4% increase) (Fig. 4A) . Consistent with the stimulation of PDE5 activity, GSNO-induced cGMP formation was significantly attenuated by transfection of Cav-1 siRNA (41 Ϯ 4% inhibition) (Fig. 4B) . Transfection of Cav-1 siRNA had no effect on basal cGMP levels (0.31 Ϯ 0.06 pmol/mg protein) compared with cells transfected with control siRNA (0.29 Ϯ 0.07 pmol/mg protein).
Augmentation of GSNO-induced PDE5 activity and attenuation of cGMP formation and muscle relaxation were also obtained in dispersed muscle cells isolated from Cav-1 Ϫ/Ϫ mice compared with wild-type mice. In muscle cells isolated from wild-type mice, GSNO (10 M) induced stimulation of PDE5 activity (432 Ϯ Fig. 3 . Disruption of caveolae augments PDE5 activity and inhibits cGMP levels and muscle relaxation in isolated muscle cells. A: caveolin-1 was immunoprecipitated with antibody specific to caveolin-1 followed by immunoblot with PDE5A antibody. Immunoprecipitates were separated by SDS-PAGE, transferred to PVDF membranes, and probed with antibody to PDE5. The proteins were visualized after incubation with secondary antibody. B-D: dispersed muscle cells from control animals were treated with methyl-␤-cyclodextrin (M␤-CD, 5 mM) or dimethyl sulfoxide. PDE5 activity (B), cGMP levels (C), and relaxation (D) in response to NO donor S-nitrosoglutathione (GSNO) (10 M) were measured as described in MATERIALS 25% increase above basal level of 463 Ϯ 78 cpm/mg protein) that was significantly augmented in Cav-1 Ϫ/Ϫ mice (802 Ϯ 46% increase above basal levels of 439 Ϯ 69 cpm/mg protein) (Fig. 5A) . Consistent with the increase in PDE5 activity, GSNOinduced cGMP formation and muscle relaxation were significantly attenuated in muscle cells from Cav-1 Ϫ/Ϫ mice (55 Ϯ 6% and 44 Ϯ 3% inhibition, respectively) (Fig. 5, B and C) .
Thus our results in muscle cells treated with M␤-CD or transfected with Cav-1 siRNA, as well as in muscle cells from Cav-1 Ϫ/Ϫ mice, suggest that PDE5 activity is negatively regulated by caveolin-1, and either disruption of caveolae or ablation of caveolin-1 results in enhanced PDE5 activity, leading to decrease in cGMP levels and muscle relaxation in response to NO donors. The basal levels of PDE5 activity and cGMP, however, were not affected either by suppression or deletion of Cav-1, and the reason for this lack of effect is unclear. Cav-3 is also expressed in gastrointestinal smooth muscle although its expression is less abundant than Cav-1. The role of Cav-3 is unknown relative to Cav-1 and PDE5 (7, 10, 30, 47) . It is possible that Cav-3 can subserve some of the roles of Cav-1 at a reduced level in the absence of Cav-1.
Sustained contraction in isolated muscle cells. We have shown previously that contraction in muscle strips and dispersed muscle cells is biphasic (34) . The initial contraction is mediated by activation of MLC kinase via Ca 2ϩ /calmodulin-dependent pathway, whereas sustained contraction is mediated by inhibition of MLC phosphatase via Rho kinase-and PKC-dependent pathways. In the present study, only sustained contraction was measured. (Fig. 6 ). This suggested that the signaling pathways mediating sustained contraction in response to G protein-coupled receptors, but not receptorindependent pathways, were altered in the Cav-1 Ϫ/Ϫ mice. We and others have shown that agonist-induced sustained MLC 20 phosphorylation and contraction were mediated by inhibition of MLCP activity via Rho kinase-mediated phosphorylation of MYPT1 at Thr 696 and PKC-mediated phosphorylation of CPI-17 at Thr 38 (8, 28, 34, 48, 56) . Each of the components involved in inhibition of MLCP activity was subsequently examined in response to both ACh and KCl.
Rho kinase/MYPT1 pathway in isolated muscle cells. Rho kinase activity was measured in isolated muscle cells from mice colon by immunokinase assay. Both ACh (1 M) and KCl (20 mM) caused a similar stimulation of Rho kinase activity in muscle cells from wild-type mice (Fig. 7) . In contrast, the response to ACh, but not KCl, was significantly reduced (53 Ϯ 3% inhibition) in muscle cells isolated from Cav-1 Ϫ/Ϫ mice (Fig. 7) . Studies in vascular smooth muscle have shown that KCl-induced contraction was associated with translocation and activation of Rho kinase (41) .
MYPT1 phosphorylation was measured using phospho-specific antibody (sc 17556-R, Santa Cruz Biotechnology) in isolated muscle cells from mice colon by immunoblot. Treatment of cells with ACh (1 M) or KCl (20 mM) for 10 min induced phosphorylation of MYPT1 at Thr 696 in muscle cells isolated from wild-type and Cav-1 Ϫ/Ϫ mice (Fig. 7) . AChinduced phosphorylation, however, was reduced in muscle cells isolated from Cav-1 Ϫ/Ϫ mice. This is consistent with the inhibition of ACh-induced Rho kinase activity in Cav-1 Ϫ/Ϫ mice. As with Rho kinase activity, phosphorylation in response to KCl was not significantly different in cells isolated from the Cav-1 Ϫ/Ϫ mice compared with wild-type mice (Fig. 7) . PKC/CPI-17 pathway in isolated smooth muscle cells. PKC activity was measured in membrane fractions of isolated muscle cells from mice colon using [ 32 P]ATP and histone as substrate. Both ACh (1 M) and KCl (20 mM) caused a similar stimulation of PKC kinase activity in muscle cells isolated Fig. 7 . Rho kinase activity and myosin phosphatase-targeting subunit 1 (MYPT1) phosphorylation in response to ACh or KCl in colonic smooth muscle. Dispersed muscle cells from the colon of wild-type and caveolin-1 knockout (Cav-1 Ϫ/Ϫ ) mice were treated with ACh (1 M) or KCl (20 mM) for 10 min. Rho kinase activity was measured by immunokinase assay. MYPT1 phosphorylation was determined by Western blot analysis using phosphospecific antibody and analyzed by densitometry. Stimulation of Rho kinase activity and phosphorylation of MYPT1 at Thr 696 in response to ACh, but not KCl, were significantly reduced in colonic muscle from Cav-1 Ϫ/Ϫ mice compared with colonic muscle from wild-type mice. Values are means Ϯ SE of 4 experiments. **P Ͻ 0.01 significant inhibition of MYPT1 phosphorylation and Rho kinase activity compared with response to ACh in wild-type mice. from wild-type mice (Fig. 8) . The response to ACh was slightly higher than that to KCl, but the difference was not significant. The response to ACh, but not KCl, was significantly reduced (51 Ϯ 5% inhibition) in muscle cells isolated from Cav-1 Ϫ/Ϫ mice (Fig. 8) . The reduction in PKC activity in the cells isolated from the Cav-1 Ϫ/Ϫ was similar to the reduction in Rho kinase activity.
CPI-17 phosphorylation was measured using phospho-specific antibody (36 -006, Millipore) in isolated muscle cells from mice colon by immunoblot. Treatment of cells with ACh (1 M) or KCl (20 mM) for 10 min caused phosphorylation of CPI-17 at Thr 38 in muscle cells isolated from wild-type and Cav-1 Ϫ/Ϫ mice (Fig. 8) . ACh-induced phosphorylation, however, was reduced in muscle cells isolated from Cav-1 Ϫ/Ϫ mice. This is consistent with the inhibition of ACh-induced PKC activity in Cav-1 Ϫ/Ϫ mice. As with PKC activity, phosphorylation in response to KCl was not significantly different in cells isolated from the Cav-1 Ϫ/Ϫ mice compared with wild-type mice (Fig. 8) .
Thus our results in muscle cells from Cav-1 Ϫ/Ϫ mice suggest that Rho kinase and PKC activity are positively regulated by caveolin-1, and deletion of caveolin-1 results in inhibition of Rho kinase and PKC activity and stimulation of MLCP activity, leading to decrease in MLC 20 phosphorylation and muscle contraction.
Measurement of ascending contraction and descending relaxation in flat-sheet preparations. The results in isolated muscle cells and muscle strips suggest that Cav-1 Ϫ/Ϫ mice have reduced responses to both ACh and NO. These are key neurotransmitters mediating the ascending contraction and descending relaxation components of the peristaltic reflex. We next tested whether these cellular effects translated to alterations in the peristaltic reflex or whether compensatory mechanism had developed in the Cav-1 Ϫ/Ϫ mice.
Stroking the mucosa of flat-sheet preparations of mouse colon elicited ascending contraction of the circular muscle orad and descending relaxation of the circular muscle caudad in a stimulusdependent manner in colonic sections from both the wild-type and Cav-1 Ϫ/Ϫ mice. The descending relaxation response was significantly reduced at each stimulus level in the Cav-1 Ϫ/Ϫ mice compared with the wild-type and ranged from 58% to 73% reduction from the response obtained in the wild-type (Fig. 9) . Similarly, the ascending contraction response was significantly reduced at each stimulus level in the Cav-1 Ϫ/Ϫ mice compared with the wild-type and ranged from 51% to 62% reduction from the response obtained in the wild-type (Fig. 9) .
Measurement of propulsion of fecal pellets. To further test the physiological significance of the reduced contraction and relaxation components of the peristaltic reflex in Cav-1 Ϫ/Ϫ mice, we examined propulsion in isolated segments from wild-type and Cav-1 Ϫ/Ϫ mice (Fig. 10) . Artificial fecal pellets placed into the orad end of colonic segments of wild-type mice were propelled distally at a velocity of 0.72 Ϯ 0.06 mm/s. The velocity of propulsion of the same artificial fecal pellets in colonic segments isolated from Cav-1 Ϫ/Ϫ mice was reduced to 0.38 Ϯ 0.04 mm/s, a 47% reduction in the velocity of propulsion.
DISCUSSION
Activation of multiple signaling pathways that regulate smooth muscle contraction and relaxation in response to excitatory and inhibitory transmitters may depend on compartmentalization of signaling components within the lipid rafts of the plasma membrane. Caveolins are a key component of the caveolae in smooth muscle, which act to regulate many major membrane functions, including organizing cell signaling components and vesicular trafficking (18, 35, 36, 55) . They have been shown to participate in excitation-contraction coupling in gut, vascular, and airway smooth muscle, but they have also been shown to have a role in the controlling relaxation pathways, particularly those involving NO (2, 4, 20, 37, 46, 50) .
In the present study, we have used caveolin-1 knockout mice (Cav-1 Ϫ/Ϫ ) to examine the role of Cav-1 in the relaxation ). Artificial fecal pellets were inserted into the orad end of intact colonic segments isolated from wild-type and Cav-1 Ϫ/Ϫ mice, and the time to traverse a defined distance was recorded. The velocity of propulsion of 5 pellets was calculated. Consistent with reduced relaxation and contraction in Cav-1 Ϫ/Ϫ mice, the velocity of fecal pellet propulsion was reduced. Values are mean Ϯ SE of 3 experiments. **P Ͻ 0.01 significant inhibition of colonic propulsion compared with wild-type mice.
response induced by NO in smooth muscle. Relaxation in response to NO is mediated via activation of sGC/cGMP/PKG pathway (28) . Muscle strips derived from Cav-1 Ϫ/Ϫ mice were used to measure relaxation in response to an NO donor, SNP, and to measure PDE5 activity and cGMP generation. Deletion of Cav-1 augmented PDE5 activity and attenuated cGMP levels and muscle relaxation. Similar patterns of results were obtained by disruption of caveolae with M␤-CD and suppression of Cav-1 with siRNA. These results demonstrate that caveolin-1 normally acts to restrain PDE5 activity and that, in the absence of caveolin-1, the enhanced PDE5 activity reduces cGMP levels and relaxation induced by NO. Lack of effect of caveolin-1 on relaxation induced by PDE5-resistant analog of cGMP supports our conclusion that the effect of caveolin-1 was mediated at the level of PDE5. Coimmunoprecipitation of PDE5 with Cav-1 further supports our conclusion of Cav-1 as a modifier of PDE5 activity. PDE5A is associated with caveolin-1, and there is no change in the association upon treatment of cells with GSNO, suggesting that the association is not stimulus dependent. Caveolae/caveolin-1 facilitate cGMP signaling, leading to smooth muscle relaxation in response to NO. Under normal conditions, stimulation of PDE5 activity in response to NO donor is blunted, leading to increased cGMP levels and optimum relaxation. In the absence of caveolin-1, the restraint exerted by caveolin-1 is unmasked, leading to augmentation of PDE5 activity and attenuation of cGMP levels and muscle relaxation. We further examined the consequence of this in the physiological setting of the descending relaxation component of peristalsis, which is a key component in efficient propulsion of fecal pellets in the colon and which is known to be mediated, in part, by NO (17, 19) . The results in the Cav-1 Ϫ/Ϫ mice confirm that this inhibitory regulation of PDE5 activity maintains relaxation during peristalsis and that loss of caveolar regulation of PDE5 activity results in impaired colonic function in the form of reduced velocity of propulsion. In gastrointestinal smooth muscle, the strength and duration of cGMP signal is determined by cGMP-specific PDE5 (6, 27, 47) . cGMP, in addition to stimulating PKG activity, stimulates PDE5 by binding to its regulatory subunit and phosphorylation via PKG (27) . PDE5 activity was also cross regulated by contractile agonist via PKC-mediated inhibition of protein phosphatase 1, leading to augmentation of PDE5 activity and inhibition of cGMP levels (29) . PDE5 is specific for the degradation of cGMP and has no effect on the degradation of cAMP (6, 9, 27, 44) .
The importance of caveolin to the function of the gut is evident from the inhibition of pellet propulsion in the Cav-1 Ϫ/Ϫ mice. The level of inhibition, about 47%, was similar to that noted for the relaxation studies in smooth muscle cells, muscle strips, and in the peristaltic reflex flat-sheet preparation. Propulsion of fecal pellets involves both the ascending contraction component and the descending relaxation component of the peristaltic reflex that act in concert to promote propulsion (17) . It is likely that the decreased pellet propulsion reflects the role of caveolin in both components. As we have shown in the present study, the descending relaxation component is reduced in Cav-1 Ϫ/Ϫ mice as a result of the impairment of the NO-mediated relaxation.
Our results also reveal that caveolae/caveolin-1 facilitates agonist-induced sustained contraction in gastrointestinal smooth muscle. Contraction in response to the G protein-coupled receptor agonist ACh, but not to a postreceptor-dependent mechanism, was strongly inhibited in smooth muscle cells isolated from Cav-1 Ϫ/Ϫ mice; this was the result of decreased stimulation of Rho kinase and PKC. Inhibition of Rho kinase/MYPT1 and PKC/CPI-17 pathway and sustained contraction in response to contractile agonists was only partial, suggesting that responses are not dependent on caveolin-1 but rather that caveolin-1 seems to facilitate the signaling pathways that mediate sustained contraction (Fig. 11) . Phosphorylation of MYPT1 by Rho kinase and CPI-17 by PKC play an important role in the regulation of MLCP activity and thus MLC 20 phosphorylation and muscle contraction (8, 28, 34, 40, 56) . The observed dependence of activation of cytosolic signaling proteins such as Rho kinase on caveolin-1 and functional caveolae suggests a link between the caveolar and cytosolic proteins and also raises the possibility that localization of these proteins to caveolar vs. noncaveolar lipid rafts differentially regulates their activation and contraction in response to G protein-coupled receptor agonists with greater activation associated with their localization to caveolar rafts. The facilitatory role of Cav-1 is likely associated with the ability of Cav-1 to recruit and organize the signaling pathways involved in muscle contraction. A point that our study did not address is the recruitment of the signaling molecules to caveolae and their interaction with Cav-1. Previous studies have demonstrated the translocation of RhoA and PKC-␣ from cytosol to caveolar regions (11, 23, 52, 54) . We propose that, in Cav-1 Ϫ/Ϫ mice, decreased Rho kinase/MYPT and PKC/ CPI-17 pathways subsequently lead to stimulation of MLCP activity and inhibition of agonist-induced muscle contraction. Thus, in the flat-sheet preparation of colon from Cav-1 Ϫ/Ϫ mice, the ascending contraction response to mucosal stimulation was inhibited by 51-62% depending on the level of stimulation. The results are consistent with the partial inhibi- Fig. 11 . Regulation of colonic smooth muscle function by caveolin-1. Caveolin-1 inhibits PDE5 activity, leading to augmentation of cGMP/PKG pathways and muscle relaxation. Caveolin-1 also facilitates Rho kinase/MYPT1 and PKC/CPI-17 pathways, leading to inhibition of myosin light chain phosphatase (MLCP) activity and increase in MLC20 phosphorylation, and sustained muscle contraction. Depletion of caveolin-1 inhibits Rho kinase/MYPT1 and PKC/CPI-17 pathways, leading to stimulation of MLCP activity and inhibition of sustained contraction. In contrast, depletion of caveolin-1 stimulates PDE5 activity, leading to inhibition of cGMP/PKG pathway and muscle relaxation. The net effect is reduction in ascending contraction and descending relaxation and pellet propulsion. Thus caveolae plays an important role in contraction and relaxation of colonic smooth muscle and the maintenance of neuromuscular function at organ level. tion of Rho kinase and PKC activity and muscle contraction in Cav-1 Ϫ/Ϫ mice and suggest that contractile response is facilitated by caveolin-1.
Our results also suggest that, although, in the absence of caveolae, signaling pathways involved in contraction and relaxation remain less operative, caveolae/caveolin-1 fine tune their function and thus the function of the muscle in response to physiologically relevant mechanisms. Even though caveolae in general and Cav-1 specifically play a major role in the signaling mechanisms that mediate contraction and relaxation of individual colonic smooth muscle cells, it is clear that, when a more complex, organ-level function such as peristalsis or propulsion is examined, the reduced responses are sufficient to maintain physiological function. This is consistent with ability of Cav-1 Ϫ/Ϫ mice to survive despite the various phenotypic changes noted in these animals (12, 22) . It also supports the notion that cellular deficits can often be difficult to translate to loss of function without examination at the intact organ or in vivo level.
In summary, the present study demonstrates that caveolins are important in both relaxation response to NO and the contraction response to ACh in the colon. These two transmitters are major mediators of the descending relaxation and ascending contraction components of the peristaltic reflex of the colon, which underlies propulsive peristalsis. The net effect of deleting Cav-1 Ϫ/Ϫ is a reduction in both components of the peristaltic reflex and reduction but not abolition of propulsion of fecal pellets.
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